Quadrant Capital Group LLC Care Dx, Inc. Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 293 shares of CDNA stock, worth $6,489. This represents 0.0% of its overall portfolio holdings.
Number of Shares
293
Previous 293
-0.0%
Holding current value
$6,489
Previous $9,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$58.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$53.4 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$48.9 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.18B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...